Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: A randomized controlled trial

Journal of Infectious Diseases

Volumn 208, Issue 9, 2013, Pages 1366-1374

  Mujugira, Andrew ^a   Magaret, Amalia S ^a   Celum, Connie ^a   Baeten, Jared M ^a   Lingappa, Jairam R ^a,b   Morrow, Rhoda Ashley ^a   Fife, Kenneth H ^c   Delany Moretlwe, Sinead ^e   De Bruyn, Guy ^d   Bukusi, Elizabeth A ^a,f   Karita, Etienne ^g   Kapiga, Saidi ^h   Corey, Lawrence ^a   Wald, Anna ^a   Campbell, Mary ^a   Coombs, Robert W ^a   Hughes, James P ^a   Mcelrath, M Juliana ^a   Mullins, James I ^a   Coetzee, David ⁱ   Were, Edwin ^j   Essex, Max ^k   Makhema, Joseph ^k   Katabira, Elly ^l   Ronald, Allan ^l   Allen, Susan ^m   Kayitenkore, Kayitesi ^m   Cohen, Craig ⁿ   Kanweka, William ^m   Vwalika, Bellington ^m   Manongi, Rachel ^o   Farquhar, Carey ^a   John Stewart, Grace ^a   Kiarie, James ^a   Inambao, Mubiana ^m   Rees, Helen ^e   Gray, Glenda ^p   Mcintyre, James ^p   Rwamba Mugo, Nelly ^a   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d SANOFI PASTEUR   (France)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g Rwanda Zambia HIV Research Group   (Rwanda)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j INDIANA UNIVERSITY   (United States)

^k BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^l MAKERERE UNIVERSITY   (Uganda)

^m EMORY UNIVERSITY   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o HARVARD UNIVERSITY   (United States)

^p UNIVERSITY OF THE WITWATERSRAND   (South Africa)

more..

Author keywords

acyclovir; Africa; HIV 1; HSV 2; serodiscordant couples; transmission

Indexed keywords

ACICLOVIR; PLACEBO;

ADULT; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; UNPROTECTED SEX; VIRUS LOAD; VIRUS TRANSMISSION;

ACYCLOVIR; AFRICA; HIV-1; HSV-2; SERODISCORDANT COUPLES; TRANSMISSION;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; COINFECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84885414788     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit333     Document Type: Conference Paper

References (27)

1. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002; 186(Suppl 1):S3-28
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004; 11(Suppl 1):24-35A.
3. Celum C, Wald A, Lingappa JR, et al. Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39
4. Reynolds SJ, Makumbi F, Newell K, et al. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: A randomised, doubleblind placebo-controlled trial. Lancet Infect Dis 2012; 12:441-8
5. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-Analysis of longitudinal studies. AIDS 2006; 20:73-83
6. Van de Perre P, Segondy M, Foulongne V, et al. Herpes simplex virus and HIV-1: Deciphering viral synergy. Lancet Infect Dis 2008; 8:490-7
7. Schacker T, Zeh J, Hu HL, Hill J, Corey L. Frequency of symptomatic and asymptomatic HSV-2 reactivations among HIV-infected men. J Infect Dis 1998; 178:1616-22
8. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995; 123:845-7
9. Corey L, Wald A, Patel R, et al. Once-Daily valacyclovir to reduce the isk of transmission of genital herpes. N Engl J Med 2004; 350: 11-20
10. Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: Two randomized trials. Int J STD AIDS 2002; 13:12-21
11. Lingappa JR, Baeten JM, Wald A, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: A randomised placebo-controlled trial. Lancet 2010; 375:824-33
12. Mujugira A, Morrow RA, Celum C, et al. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sex Transm Infect 2011; 87:238-41
13. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (Immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-7
14. Ashley RL. Current concepts of laboratory diagnosis of herpes simplex infection. In: Sacks SL, Straub S, Whitley RJ, Griffiths PD, ed. Clinical management of herpes viruses. Washington DC: IOS Press, 1995:137-71
15. Lingappa JR, Kahle E, Mugo N, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: The partners study. PLoS One 2009; 4:e5272
16. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190:1374-81
17. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: Results of an international, multicenter, double-blind randomized clinical trial. Sex Transm Dis 1997; 24:481-6
18. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus acyclovir in patient-initiated treatment of recurrent genital herpes: A randomized, double-blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med 1997; 73:110-16
19. Johnston C, Saracino M, Kuntz S, et al. Standard-Dose and high-Dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: Three randomised, open-label, cross-over trials. Lancet 2012; 379:641-7
20. Fuchs J, Celum C, Wang J, et al. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis 2010; 201:1164-8
21. Lu Y, Celum C, Wald A, et al. Acyclovir achieves lower concentration in African HIV-seronegative, HSV-2 seropositive women compared to non-African populations. Antimicrob Agents Chemother 2012; 56:2777-9
22. Ramjee G, Williams B, Gouws E, Van Dyck E, De Deken B, Karim SA. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr 2005; 39:333-9
23. Chohan V, Baeten JM, Benki S, et al. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya. Sex Transm Infect 2009; 85:489-92
24. de Bruyn G, Shiboski S, van der Straten A, et al. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect 2011; 87:301-5
25. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 2009; 199:945-9
26. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37:319-25
27. Martin ET, Koelle DM, Byrd B, et al. Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains. J Clin Microbiol 2006; 44:2541-6